Targeting HER 1 and 2 in breast cancer with lapatinib
Numerous clinical trials support the biological relevance of the HER2 oncoprotein in breast cancer. In spite of improved outcomes, overexpression of the receptor is associated with increased risks of disease relapse, even in patients with early, and potentially curable, disease. Until recently, deve...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Kitap |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
| Konular: | |
| Online Erişim: | Connect to this object online. |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
| Yer Numarası: |
A1234.567 |
|---|---|
| Kopya Bilgisi 1 | Kütüphanede |